Literature DB >> 964550

Different susceptibilities of the urinary bladder epithelium of animal species to three nitroso compounds.

M Hirose, S Fukushima, M Hananouchi, T Shirai, T Ogiso.   

Abstract

Differences in the susceptibilities of the urinary bladder epithelium of Wistar rats, ICR mice, Syrian golden hamsters, and Hartley guinea pigs to three N-nitroso compounds, N-butyl-N-(4-hydroxybutyl)nitrosamine, N-ethyl-N-(4-hydroxybutyl)nitrosamine, and N-butyl-N-(3-carboxypropyl)nitrosamine, were examined histologically. The urinary bladder epithelium of rats was the most susceptible to all three compounds, and especially to N-ethyl-N-(4-hydroxybutyl)nitrosamine, and bladder cancers developed in all the rats given this compound. The bladder epithelium of mice was less susceptible than that of rats but, although the incidence of cancer was lower than in rats, that of cancer with invasion was higher. Hamsters were far less susceptible than mice, and cancer developed only in 3 of 41 animals given N-ethyl-N-(4-hydroxybutyl)nitrosamine. Guinea pigs were the least susceptible of the 4 species and no tumors were found. Hisotlogically, most of the tumors induced in rats and mice were transtitional cell carcinomas. The incidence of undifferentiated carcinoma was higher in mice than in rats and cellular or structural atypism of the cancer was also greater in mice. Cancers induced in hamsters were all transitional cell carcinomas showing invasion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 964550

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  13 in total

Review 1.  Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens.

Authors:  Yuesheng Zhang
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2013       Impact factor: 3.781

2.  Dose-response study of urinary bladder carcinogenesis in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  N Ito; T Shirai; S Fukushima; M Hirose
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  NTPDase3 and ecto-5'-nucleotidase/CD73 are differentially expressed during mouse bladder cancer progression.

Authors:  Liliana Rockenbach; Elizandra Braganhol; Fabrícia Dietrich; Fabrício Figueiró; Manoella Pugliese; Maria Isabel Albano Edelweiss; Fernanda Bueno Morrone; Jean Sévigny; Ana Maria Oliveira Battastini
Journal:  Purinergic Signal       Date:  2014-01-26       Impact factor: 3.765

4.  Biological behavior of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide induced carcinoma of the transitional epithelium in the rat.

Authors:  H Kiel; H D Adolphs; J Thiele; L Steffens
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978

5.  Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.

Authors:  K Babaya; S Takahashi; H Momose; H Matsuki; K Sasaki; S Samma; S Ozono; Y Hirao; E Okajima
Journal:  Urol Res       Date:  1987

6.  Pathobiology and chemoprevention of bladder cancer.

Authors:  Takuji Tanaka; Katsuhito Miyazawa; Tetsuya Tsukamoto; Toshiya Kuno; Koji Suzuki
Journal:  J Oncol       Date:  2011-09-15       Impact factor: 4.375

Review 7.  The canopic worm: role of bilharziasis in the aetiology of human bladder cancer.

Authors:  R M Hicks
Journal:  J R Soc Med       Date:  1983-01       Impact factor: 18.000

8.  Effect of promoters on incidence of bladder cancer in experimental animal models.

Authors:  R M Hicks
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

9.  Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon.

Authors:  R M Hicks; C James; G Webbe
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640

10.  Time- and dose-dependent induction of invasive urinary bladder cancers by N-ethyl-N-(4-hydroxybutyl)nitrosamine in B6C3F1 mice.

Authors:  S Tamano; A Hagiwara; E Suzuki; M Okada; T Shirai; S Fukushima
Journal:  Jpn J Cancer Res       Date:  1991-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.